* Chimerix Inc CMRX.OQ CMRX.O is expected to show a rise
in
quarterly revenue when it reports results on March 2.
* The Durham North Carolina-based company is expected to
report
a 951.1% increase in revenue to $483.5 thousand from $46
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Chimerix Inc is for
a
loss of 24 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Chimerix
Inc is
$6.5, above its last closing price of $1.57.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 2.13 2.14 2.75 Beat 28.6
Jun. 30 2022 -0.25 -0.24 -0.27 Missed -11.6
Mar. 31 2022 -0.33 -0.33 -0.28 Beat 15.6
Dec. 31 2021 -0.32 -0.17 -0.45 Missed -157.1
Sep. -0.14 -0.15 -0.21 Missed -40.6
30 2021
Jun. 30 2021 -0.19 -0.19 -0.21 Missed -11.5
Mar. 31 2021 -0.27 -0.41 -1.21 Missed -192.3
Dec. 31 2020 -0.20 -0.20 -0.19 Beat 3.1
This summary was machine generated February 24 at 19:37 GMT.
All figures in US dollars unless otherwise stated